|Bid||9.45 x 200|
|Ask||9.65 x 100|
|Day's range||9.16 - 9.81|
|52-week range||5.90 - 25.17|
|PE ratio (TTM)||N/A|
|Earnings date||30 Oct 2017 - 3 Nov 2017|
|Forward dividend & yield||N/A (N/A)|
|1y target est||23.17|
The Ames, Iowa-based company said it had a loss of 69 cents per share. The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for ...
NewLink Genetics Corporation , a late-stage biopharmaceutical company, today announced that it intends to offer and sell, subject to market conditions, up to $50,000,000 of shares of its common stock in an underwritten public offering.
ASCO's abstract drop reveals the progress being made in attacking cancer and, inevitably, moves stocks both large and small.